Therapeutic potential of endothelin inhibitors in canine hemangiosarcoma.

[1]  A. Peacock,et al.  Ambrisentan for the treatment of adults with pulmonary arterial hypertension: a review , 2015, Current medical research and opinion.

[2]  T. Miyasho,et al.  Big endothelin-1 as a tumour marker for canine haemangiosarcoma. , 2015, Veterinary journal.

[3]  Y. Naito,et al.  Correlated expression levels of endothelin receptor B and Plexin C1 in melanoma. , 2015, American Journal of Cancer Research.

[4]  S. Paltrinieri,et al.  Big-endothelin 1 (big ET-1) and homocysteine in the serum of dogs with chronic kidney disease. , 2013, Veterinary journal.

[5]  T. Uchide,et al.  A new treatment for human malignant melanoma targeting L-type amino acid transporter 1 (LAT1): a pilot study in a canine model. , 2013, Biochemical and biophysical research communications.

[6]  M. Göritz,et al.  Canine splenic haemangiosarcoma: influence of metastases, chemotherapy and growth pattern on post-splenectomy survival and expression of angiogenic factors. , 2013, Journal of comparative pathology.

[7]  N. Dimitrov,et al.  Endothelin-1 Enriched Tumor Phenotype Predicts Breast Cancer Recurrence , 2013, ISRN oncology.

[8]  P. Polakis,et al.  An Antibody–Drug Conjugate Targeting the Endothelin B Receptor for the Treatment of Melanoma , 2011, Clinical Cancer Research.

[9]  A. Murai,et al.  Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes , 2009, BMC Cancer.

[10]  B. Sancak,et al.  Serum big endothelin-1 levels in female patients with breast cancer. , 2008, International immunopharmacology.

[11]  F. Spinella,et al.  The endothelin axis in cancer: the promise and the challenges of molecularly targeted therapy. , 2008, Canadian journal of physiology and pharmacology.

[12]  J. Pernow,et al.  The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. , 2007, Cardiovascular research.

[13]  H. Namba,et al.  Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. , 2007, Endocrinology.

[14]  T. Uchide,et al.  Elevated endothelin-1 expression in dogs with heartworm disease. , 2005, The Journal of veterinary medical science.

[15]  M. Gassmann,et al.  High altitude training of dogs results in elevated erythropoietin and endothelin-1 serum levels. , 2004, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[16]  T. Hagemann,et al.  A Role for Endothelin-2 and Its Receptors in Breast Tumor Cell Invasion , 2004, Cancer Research.

[17]  Annette N Smith.  Hemangiosarcoma in dogs and cats. , 2003, The Veterinary clinics of North America. Small animal practice.

[18]  J. Nelson,et al.  Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  K. Roessler,et al.  Evaluation of big endothelin-1 concentrations in serum and ventricular cerebrospinal fluid after early surgical compared with nonsurgical management of ruptured intracranial aneurysms. , 2000, Neurosurgical focus.

[20]  T. Masaki.  The endothelin family: an overview. , 2000, Journal of cardiovascular pharmacology.

[21]  P. Patterson,et al.  An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Catt,et al.  Endothelins as Autocrine Regulators of Tumor Cell Growth , 1998, Trends in Endocrinology & Metabolism.

[23]  J. Brooks,et al.  Methylation of the 5' CpG island of the endothelin B receptor gene is common in human prostate cancer. , 1997, Cancer research.

[24]  S. Magnuson,et al.  Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. , 1996, Cancer research.

[25]  R. Dubielzig,et al.  Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  J. Nelson,et al.  Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate , 1995, Nature Medicine.

[27]  E. Levin.  Mechanisms of disease : endothelins , 1995 .